Summit Securities Group’s Carisma Therapeutics CARM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-5,210
Closed -$8K 490
2024
Q2
$8K Buy
+5,210
New +$8K ﹤0.01% 333